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Summary
Objective: To investigate the role of adenosine in chondrocyte death in murine osteoarthritis (OA).
Methods: 50-Nucleotidase (50NT) generates adenosine. Enzyme activity was measured histochemically in normal murine and osteoarthritic
STR/ort strain tibial cartilage. Adenosine-mediated cell death was investigated in MC615 chondrocyte cultures. Adenosine receptors (ARs)
were assessed by reverse transcriptase polymerase chain reaction (RT-PCR). Cellular uptake of [3H] adenosine was measured with or without
the inhibitor, nitrobenzylthioinosine (NBTI). Cell death was assessed by cell counting and DNA laddering following selective receptor stimu-
lation, or after modulating adenosine metabolism with adenosine deaminase (ADA) or adenosine kinase (AK) inhibitors [erythro-9-(2-hydroxy-
3-nonyl)adenine (EHNA) and Iodotubericidin (Itub)], or with homocysteine (HC). Markers of apoptosis were assessed by Western blotting. Cell
studies were validated by incubating normal murine knee joints in a medium containing adenosine and metabolic inhibitors. Apoptotic chon-
drocytes were identiﬁed with the TUNEL reaction.
Results: 50NT activity in STR/ort tibial cartilage increased with development of OA, especially close to OA lesions. Adenosine induced MC615
cell death in the presence of ADA inhibition (100 mM EHNA), or 1 mM HC, or both. Adenosine uptake, mediated by NBTI-sensitive adenosine
transporters, was required for cell death. ARs were expressed (A2b> A2a>A1) but were not involved in mediating cell death. Cell death in-
volved the activation of caspase-3 and DNA fragmentation and was prevented by inhibiting caspase activity. However, neither caspase-8 nor
caspase-9 was detected. AdenosineþEHNA induced chondrocyte apoptosis in normal murine knee joints.
Conclusion: Increased adenosine production may induce chondrocyte apoptosis and play a role in OA in STR/ort mice.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Purines are important cellular metabolites, which are in-
volved in a wide variety of processes. They are generated
by 50-nucleotidases (50NT), a family of enzymes which de-
phosphorylate ribo- and deoxyribonucleoside monophos-
phates (e.g., adenosine monophosphate (AMP)) to yield
their respective nucleoside (e.g., adenosine). In human tis-
sues there are ﬁve cytosolic, one mitochondrial and one ex-
tracellular 50-nucleosidase. The latter, ecto-50nucleotidase
(ecto-50NT), is a glycosylphosphoinositol-membrane linked
enzyme. These enzymes have many important physiologi-
cal functions ranging from involvement in maintaining bal-
anced nucleotide triphosphate pools in energy metabolism
to roles in cellular signalling1. Adenosine has an important
physiological signalling role in the peripheral and central
nervous systems2. However, excessive adenosine levels
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mediated cell death seems to vary in different cell types.
Two mechanisms of cytotoxicity exist, and are initiated ei-
ther extracellularly or intracellularly, depending on the mode
of action (Fig. 1). Extracellular adenosine can interact with
purine receptors. Investigation of the role of these receptors
in cytotoxic effects remains incomplete, since few earlier
studies used selective receptor agonists7. Szondy8 treated
human thymocytes with the adenosine analogue 2-chloro-
adenosine (2-CA) and various adenosine receptor (AR) ag-
onists. 2-CA was the most potent at selectively depleting
thymocyte subpopulations. The mechanism was Ca2þ-me-
diated and appeared to involve cyclic AMP (cAMP). In other
studies, the cytotoxic effects of adenosine were found to be
mediated via various AR subtypes9,10. However, it is note-
worthy that some studies have shown that activation of
AR subtypes by adenosine can have a protective effect
on the cells. This is largely due to its inhibitory effect on
NO release11,12.
Dawicki et al.5 showed that adenosine had a cytotoxic ef-
fect on cultured pulmonary artery endothelial cells and that
for it to exert this effect, it had to enter the cell. Other studies
have shown that the main route of adenosine uptake is via
a series of adenosine transporters13. Once in the cell,6
487Osteoarthritis and Cartilage Vol. 14, No. 5Fig. 1. Overview of purine metabolic pathways. Adenosine is produced from 50AMP, either extracellularly by ecto-50NT, or intracellularly by
cytosolic-50NT. Extracellular adenosine can signal via ARs which are coupled to G-proteins (abg subunits) regulating the activity of AC
and the production of cAMP, or it can enter the cell via the adenosine transporter. In the cell, adenosine is metabolised to uric acid after con-
version to inosine by ADA, or converted to AMP via AK. Alternatively, adenosine can be diverted into the HC pathway. High levels of aden-
osine can induce cell death by mechanisms dependent on either interaction with ARs or cellular uptake via the adenosine transporter,
depending on the cell type (for details see the text). Figure modiﬁed from Ceruti et al.3.adenosine can be metabolised by multiple pathways14
(Fig. 1), a degradatory pathway converts adenosine to ino-
sine and then to uric acid. The conversion to inosine is me-
diated by adenosine deaminase (ADA). Errors in this
pathway are clinically manifested in severe combined im-
munodeﬁciency syndrome (SCIDS) patients. These pa-
tients either lack ADA or the enzyme is grossly inhibited.
As a result, they have massive thymocyte deletion and
overwhelming immunodeﬁciency15. Another disorder asso-
ciated with this pathway is gout, in which the accumulation
of uric acid crystals within the joint is the major feature16.
This disorder is due to excessive activity of the pathway.
A second pathway available to adenosine is the adenosine
kinase (AK) pathway. In this, adenosine is converted to
AMP by AK. AMP is further metabolised to adenosine tri-
phosphate (ATP) and dATP. The balance between ATP
and dATP is important in maintaining efﬁcient DNA repair.
A third pathway is the homocysteine (HC) pathway (see
Fig. 1) in which S-adenosylmethionine (SAM) is converted
to S-adenosylhomocysteine (SAH), where SAM acts as
a methyl donor to methyl transferases. Alterations in the
equilibrium of this reaction have been reported in several
pathologies including atherosclerosis17, stroke18 and throm-
bosis19. A possible link with Alzheimer disease has also
been proposed20.
Elevated levels of 50NT have been found in the synovial
ﬂuid of both osteoarthritis (OA) and rheumatoid arthritis
(RA) patients21,22. Moreover, addition of adenosine to chon-
drocyte cultures was reported to have cytotoxic effects21.
This led to our hypothesis that the generation of adenosine
may trigger chondrocyte apoptosis in arthritis. Chondrocyte
apoptosis is a well established feature of both human23e25
and murine26 OA. Thus we investigated 50NT activity in tib-
ial cartilage of STR/ort mice, a naturally occurring model of
OA27, and the mechanism of adenosine-mediated cell
death in murine MC615 chondrocytes.Methods
IN VIVO EXPERIMENTS
Inbred male STR/ort mice from the Imperial College colony
were sacriﬁced at 6, 12, 20 and 40 weeks of age. Sex and
age-matched CBA mice, a strain which has not been shown
to develop OA at the ages studied, were purchased from
Charles River Laboratory (Margate, Kent, UK). Mice were
killed by cervical dislocation. The knee joints were dissected
out and prepared for sectioning, as described in detail pre-
viously26. After chilling to 70(C in n-hexane cooled by in-
dustrial methylated spirits and solid carbon dioxide, frozen
knee joints were mounted on metal chucks (with the patella
facing up) for sectioning. Sectioning was carried out in the
anterior to the posterior direction. Serial 10 mm sections
were cut through the whole joint and mounted onto
chrome-alum coated microscope slides. Sections not imme-
diately required were stored at 80(C for future use.
The TUNEL assay (Apoalert DNA Fragmentation Assay,
Clontech Inc, Palo Alto, CA, USA) was performed, as previ-
ously26, following the manufacturer’s protocol. Brieﬂy, sec-
tions ﬁxed with 4% paraformaldehyde/phosphate buffered
saline (PBS) were washed in PBS and subjected to brief
proteinase K digestion (10 mg/ml) (5 min, room tempera-
ture). Sections were again ﬁxed, washed and incubated
with equilibrium buffer, before application of 50 ml of reac-
tion mixture (45 ml labelling solution, 4 ml equilibrium buffer,
1 ml transferase enzyme) to each slide. Following incubation
(37(C for 60 min), the slides were treated with 1 saline-
sodium citrate (SSC) solution before mounting with a ﬂuo-
rescence mounting media (Vector Laboratories, Paisley,
UK). Nuclei of apoptotic cells were stained green by this
procedure whilst the intact DNA of normal cells was stained
red by propidium iodide in the medium.
The 50NT activity of STR/ort and CBA mouse knee joint
cartilage chondrocytes was detected in unﬁxed cryostat
488 D. Mistry et al.: Role of adenosine in chondrocyte deathsections using a histochemical method28. Sections were in-
cubated for 5 min at 37(C in medium containing 4 mM AMP
as a substrate after which they were washed and treated
with 0.1% ammonium sulphide solution. 50NT activity was
detected by the formation of a black/brown precipitate of
lead sulphide. Some sections were incubated in the pres-
ence of the 50NT inhibitor nickel chloride (10 mM), as a neg-
ative control28.
CELL CULTURE EXPERIMENTS
An immortalised murine chondrocyte cell line (MC615)
was a kind gift from Dr Bjorn Olsen (Harvard Medical
School, Boston). Cells (passages 19e23) were maintained
in Dulbecco’s Modiﬁed Essential Medium (DMEM)/Ham’s
F12 (50:50) (Invitrogen, Paisley, UK) supplemented with
10% foetal calf serum, penicillin, streptomycin, fungizone
(PSF), and 10 mM HEPES. Media were changed every
2e3 days. For experiments, cells were plated at
1.6 106 cells/well in 6-well plates, unless speciﬁed other-
wise. Cells were allowed to settle for 24 h, after which the
medium was changed. Treatment of the cells was carried
out on the following day.
To investigate the effect of inhibiting adenosine metabolic
pathways, cells were pre-incubated for 30 min at 37(C with
whole medium containing either the ADA inhibitor, erythro-
9-(2-hydroxy-3-nonyl)adenine (EHNA, 10 mM and 100 mM),
or the AK inhibitor, Iodotubericidin (Itub, 1 mM and 10 mM).
Following pre-incubation, cells were treated with 5 mM
adenosine and/or 1 mM HC in the presence or absence of
the compounds for 24 h at 37(C. Treatment was stopped
by aspirating the medium and washing the cell layer, after
which the cells were counted. The cell layers were washed
twice with sterile PBS before addition of 1 ml of trypsin/
EDTA (Invitrogen). Cells were trypsinised for 3 min at
37(C. The trypsinised cells were transferred to a tube con-
taining an excess of medium and centrifuged at 1000 rpm
for 10 min. The supernatant was discarded and the pellet
resuspended in 1 ml of medium. Cells were counted using
a haemocytometer. Dishes were examined under the micro-
scope to ensure that all cells had been removed.
To investigate adenosine uptake, MC615 cells were plat-
ed at 2 105 cells/well in 24-well plates. The cells were al-
lowed to settle for 24 h before washing each well with
3 1 ml Hank’s Balanced Salt Solution (HBSS). All wells
were pre-incubated for 15 min at 37(C, with medium con-
taining 100 mM EHNA (SigmaeAldrich, Poole, Dorset, UK)
in the presence or absence of the adenosine transporter
inhibitor, nitrobenzylthioinosine (NBTI, 1.0e100 mM). To ini-
tiate uptake, [3H] adenosine was added to a ﬁnal concen-
tration of 10 mCi/ml and the cells incubated for a further
5 min. Each treatment was conducted in duplicate. Follow-
ing incubation the medium was collected and the cell layer
washed extensively three times with ice-cold HBSS. A
0.5 ml of 1 M NaOH was added to each of the wells and
the cell layer left to solubilise overnight at 37(C. Radioac-
tivity levels were measured by adding 100 ml of the radio-
active sample to 4 ml of scintillation ﬂuid (Ecoscint;
National Diagnostics, Atlanta, GA, USA) and the counts
measured using a Beckman LS6000SC scintillation counter.
In control experiments, inulin [14C]carboxylic acid,
which is impermeable to cells, was used as a negative
control.
A DNA fragmentation assay was used to assess the ef-
fect of adenosine on apoptosis in MC615 chondrocytes.
This was performed using the DNA ladder isolation kitfrom Oncogene Research Products (CN Biosciences, Not-
tingham, UK), following the manufacturer’s protocol. Cell
cultures were treated with compounds for 9 h after which
the media were transferred into separate tubes and the
cell layers washed three times with sterile PBS. The aspi-
rated media fractions were centrifuged to collect any ﬂoat-
ing cells. The resulting cell pellet was treated in the same
manner as the cell layers. Five hundred microlitres of ex-
traction buffer was added directly to the monolayer in
each well and the plate rocked for 10 min at room temper-
ature. The cell lysate was transferred into sterile eppen-
dorfs and left on ice for 30 min before being centrifuged
(room temperature, 5 min, 5000 rpm). The supernatant
was transferred to a clean eppendorf and 20 ml of solution
2 was added before incubating for 60 min at 37(C. Follow-
ing incubation, 25 ml of solution 3 was added to each of
the tubes, after which the samples were incubated over-
night at 50(C. To precipitate DNA, 2 ml Pellet Paint Co-
precipitant, 60 ml sodium acetate (pH 5.2) and 662 ml
isopropanol were added and the samples incubated for
2 min at room temperature. Samples were then centrifuged
at 14,000 rpm at 4(C, after which the supernatants were
removed and the DNA pellets washed with 75% ethanol,
followed by 100% ethanol. After the last wash, the super-
natant was discarded and the samples were air dried be-
fore being dissolved in resuspension buffer. To visualise
DNA laddering, samples were mixed with 6 gel loading
buffer and loaded onto a 1.5% agarose gel. The gel was
stained with 0.5 mg/ml ethidium bromide and laddering vi-
sualised using an UV illuminator.
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION
(RT-PCR)
To investigate AR expression by MC615 chondrocytes,
RNA was isolated from cells with RNAzol B reagent (Ambion
Ltd, Huntingdon, UK), following the manufacturer’s protocol,
after which it was resuspended in diethyl pyrocarbonate
(DEPC)-treated water and the concentration measured
spectrophotometrically at 260 nm. Total RNA (5 mg) was re-
verse transcribed using Superscript II and random hexamers
(Invitrogen, Paisley, UK) and 2 ml of the transcribed product
was used in a 100 ml PCR reaction mix containing 1 PCR
buffer, 10 mM dNTP mixture, 10 mM primer pair, the appro-
priate concentration of MgCl2 and 1 ml of Taq DNA polymer-
ase (Invitrogen). PCR reactions were carried out in a Hybaid
Omnigene thermocycler. Following the initial denaturation
step (94(C for 5 min), each PCR cycle comprised denatur-
ation (94(C for 45 s), annealing (45 s) and extension
(72(C for 45 s). The annealing temperature was optimised
for each primer pair. A1, A2a and A3 purine receptor primers
required 60(C, whereas the A2b receptor and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) primers re-
quired 56(C. The MgCl2 concentrations for PCR reactions
were also optimised, receptors A1, A2a, and A3, and
GAPDH requiring 1.5 mM and receptor A2b requiring
2 mM. A ﬁnal cycle of 72(C for 10 min was performed to
complete any partially ampliﬁed products. A total of 40
PCR cycles were performed for each AR primer pair, but
only 25 cycles were required for GAPDH. The PCR condi-
tions were chosen to be non-saturating in all cases. PCR
products were electrophoresed on 1.5% agarose gels and vi-
sualised using an UV transilluminator. The band densities
were quantiﬁed using the NIH Image program.
Primer sequences were designed using Genejockey and
were as follows: A1 AR, sense: GCC TGT CCT GTC CTC
ATC CTC ACC; antisense: CAG ACG AAG AAG TTG
489Osteoarthritis and Cartilage Vol. 14, No. 5AAG TAG ACC. A2a AR, sense: TTC TTC TGC TCC ACG
TGC CAG C; antisense: TGG TGC TCC TGG GTA AGA
AGC. A2b AR, sense: AGA ATG TGG TCC CCA TGA
GC; antisense: ATG GGG TTG ACA ACT GAA TTG G.
A3 AR, sense: GTG TGA GGT GGC TGT CTA TCC
TGG; antisense: TCT TCC AGA GAC CAT ACC ACC
ACG. GAPDH, sense: ACC ACA GTC CAT GCC ATC
AC; antisense: TCC ACC ACC CTG TTG CTG TA.
SODIUM DODECYL SULPHATE POLYACRYLAMIDE GEL
ELECTROPHORESIS (SDS-PAGE)
Chondrocyte cell layer samples were extracted in radio-
immunoprecipitation (RIPA) buffer (0.5% sodium deoxycho-
late, 1% NP40 and 0.1% sodium dodecyl sulphate (SDS))
and transferred to an eppendorf. The cell lysate was drawn
through a 21-gauge needle to achieve a uniform suspen-
sion. The protein concentration was measured with the
Bradford assay and known protein concentrations of each
sample were mixed with 3 sample buffer (containing b-
mercaptoethanol and 1 protease inhibitors) and electro-
phoresed on a 7.5% or 15% SDS-polyacrylamide gel, prior
to transfer to an activated polyvinylidene ﬂuoride (PVDF)
membrane in transfer buffer containing 20 mM Tris,
390 mM glycine and 40% v/v methanol. Following transfer
the membrane was washed in PBS and blocked using 5%
non-fat milk (diluted in Tris buffered saline (TBS)-Tween)
at room temperature for 60 min. Blots were probed with pri-
mary antibodies to caspase-3 (Research Diagnostics Inc,
Flanders, NJ, USA; 1:400) or poly adenosine diphosphate
(ADP)-ribose-polymerase (PARP) (Serotec, Oxford, UK;
1:5000) overnight at 4(C after which they were washed
with TBST and incubated with an horse radish peroxide
(HRP)-conjugated secondary antibody (DAKO, Ely, Cam-
bridgeshire, UK; 1:2000) for 1 h at room temperature. Anti-
body binding was visualised with the ECL kit (Amersham
Life Sciences, Little Chalfont, Buckinghamshire, UK).
IN VIVO VALIDATION OF ADENOSINE-INDUCED
CHONDROCYTE DEATH
Organ culture experiments were carried out on disarticu-
lated knee joints from 8-week-old CBA mice. Joints were in-
cubated at 37(C for 24 h in media containing 100 mM EHNA
or 5 mM adenosineþ 100 mM EHNA. Following treatmentthe joints were snap frozen, sectioned and the sections an-
alysed using the TUNEL assay.
STATISTICAL ANALYSIS
Results were assessed using analysis of variance
(ANOVA) for multiple comparisons with Bonferroni
corrections.
Results
50NT ACTIVITY IN NORMAL AND OSTEOARTHRITIC ARTICULAR
CARTILAGE
50NT activity was assessed in the articular cartilage of the
stiﬂe (knee) joints of STR/ort mice of different ages, which
exhibited varying degrees of OA damage. The latter was
graded on a scale of 0e6, as described previously27, where
0 corresponds to normal cartilage and 6 corresponds to
80%, or greater, loss of the articular cartilage. Age-matched
CBA mice were used as controls. Enzyme activity in STR/
ort mice varied both with age and lesion severity. Young
STR/ort mice (6 weeks old) had no OA lesions and showed
very little enzyme activity in the tibial plateau cartilage ex-
cept in some superﬁcial zone chondrocytes on the medial
side [Fig. 2(A, B)]. Control sections which had been treated
with the 50NT enzyme inhibitor nickel chloride showed sig-
niﬁcantly lower levels [Fig. 2(C)]. Some degree of activity
is expected as nickel chloride only inhibits 80% of the total
activity28. 50NT activity in tibial cartilage of young CBA mice
[Fig. 2(D)] was also associated predominantly with superﬁ-
cial zone chondrocytes on the medial side, as in STR/ort
mice.
By 20 weeks of age most STR/ort mice develop focal OA
lesions of varying severity in the medial tibial plateau whilst
the lateral plateau is almost always spared27. 50NT activity
is prominent at this age in the chondrocytes of the medial
plateau where low grade histopathological lesions have de-
veloped and is found in cells throughout the full depth of the
cartilage [Fig. 3(A)]. A similar level of activity and distribu-
tion is seen in cartilage of older mice with low grade lesions
[Fig. 3(B)]. Similarly chondrocytes in cartilage adjacent to
more advanced lesions show evidence of 50NT activity
throughout the full depth of the cartilage [Fig. 3(C)] although
those on the margin of the lesion frequently show little or noFig. 2. Histochemical detection of 50NT activity in articular cartilage of young STR/ort and CBA mice. (A) Medial and (B) lateral tibial plateau in
6-week-old STR/ort mice. Only low levels of enzyme activity were detected, mainly in the superﬁcial zone. The histology of the cartilage is
normal. (C) A 6-week-old STR/ort medial tibial plateau. 50NT activity was inhibited by incubating sections with the 50NT inhibitor nickel chloride.
(D) Age-matched CBA mouse medial tibial plateau showing a similar distribution of 50NT activity. ac, articular cartilage; cc, calciﬁed cartilage;
and m, meniscus. Original magniﬁcation, 37.
490 D. Mistry et al.: Role of adenosine in chondrocyte deathFig. 3. Histochemical detection of 50NT activity in articular cartilage of older STR/ort mice with OA lesions of varying severity. (A) A 20-week-
old STR/ort mouse, medial tibial plateau, grade 2 OA lesion (arrow). High levels of enzyme activity are associated with chondrocytes through-
out the full depth of the cartilage and are particularly prominent in the superﬁcial and mid zones adjacent to the lesion. (B) A 40-week-old STR/
ort mouse, medial tibial plateau, grade 2 lesion (arrow) showing a similar distribution and high level of 50NT activity as in the younger mouse
with a grade 2 lesion (panel A). (C) A 40-week-old STR/ort mouse, medial tibial plateau, grade 4 lesion (arrows indicate the cartilage surface at
the lesion site). 50NT activity is associated with chondrocytes throughout the full depth of the cartilage close to the lesion but is low or absent in
some lacunae situated at the margins of the lesion, possibly due to chondrocyte death in this location. (D) Chondrocytes in the same medial
cartilage, but located at some distance from the focal lesion area show only low levels of 50NT activity. (E) The lateral plateaux at all ages show
only modest levels of activity, mainly in the superﬁcial zone. (F) A 20-week-old CBA mouse medial tibial cartilage. Older CBA mice show a sim-
ilar distribution and level of 50NT activity to that seen in young CBA mice. ac, articular cartilage; cc, calciﬁed cartilage; and m, meniscus. Orig-
inal magniﬁcations, AeC, 45; and DeF, 40.activity [Fig. 3(C)]. These same cells also show loss of ex-
pression of aggrecan and other proteins and may be pre-
apoptotic, or have already died, as discussed previously27.
Chondrocytes in cartilage located at some distance from the
lesion show only low levels of 50NT activity [Fig. 3(D)]. Sim-
ilarly chondrocytes in the lateral tibial plateau have only
modest levels of 50NT activity, mainly conﬁned to the super-
ﬁcial zone [Fig. 3(E)]. 50NT activity in the medial cartilage of
CBA control mice is also largely conﬁned to chondrocytes of
the superﬁcial zone [Fig. 3(F)] and levels are similar to
those found in younger CBA mice [Fig. 2(D)]. In all cases
50NT activity detected in either older STR/ort or older CBA
mouse cartilage was greatly reduced in the presence of
the enzyme inhibitor nickel chloride. Thus, in summary,
the development of focal osteoarthritic lesions in the medial
tibial plateau cartilage of the STR/ort mouse is accompa-
nied by increased 50NT activity in chondrocytes throughout
the full depth of cartilage adjacent to the lesional area.
AR EXPRESSION IN MURINE MC615 CHONDROCYTES
The expression of AR subtypes in murine chondrocytes
(MC615) was investigated by RT-PCR. The speciﬁc primers
to each receptor were checked initially against a total RNA
panel (Clontech, Palo Alto, CA, USA) containing RNA from
a series of mouse tissues and the previously reported pat-
tern of expression was found (data not shown). Analysis
of mRNA from MC615 cells showed the expression of three
of the four receptor subtypes. The A2b receptor is the most
abundantly expressed, with the A1 and A2a receptors being
expressed at a lower level. A3 transcripts were absent
[Fig. 4(A)]. These differences, when represented graphical-
ly, show a 6-fold difference between A1 and A2b and a 3-
fold difference between A2a and A2b [Fig. 4(B)].Fig. 4. Differential expression of AR subtype transcripts in murine
chondrocytes (MC615 cells). (A) Total RNA from MC615 cells
(MC) was reverse transcribed and used for PCR. The PCR prod-
ucts were electrophoresed on a 1.5% gel to assess comparative
levels of the AR subtype expression. GAPDHwas used as a loading
control. Band sizes: A1, 316 bp; A2a, 391 bp; and A2b, 345 bp. (B)
Quantiﬁcation of PCR bands using densitometry analysis and NIH
Image software. Two further independent experiments gave very
similar results.
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ted for 1 h with selective and non-selective agonists of
these receptors (C6-cyclopenyladenosine (CPA) for A1,
CGS 21860 for A2a, 50-(Nethylcarboxamido) adenosine
(NECA) and adenosine which is non-selective for A1/A2 re-
ceptors) after which cAMP levels and DNA fragmentation
were measured. Whilst the anticipated changes in cAMP
levels occurred, as detected by a cAMP enzyme immuno-
assay (Amersham Biosciences, Chalfont St. Giles, Bucks,
UK), no DNA fragmentation was detected in response to
any of these agonists (data not shown).
ADENOSINE UPTAKE BY MC615 CELLS
Adenosine can enter cells via adenosine transporters.
The presence of these transporters on the surface of chon-
drocytes had not been reported previously so experiments
were carried out to determine whether they exist on murine
chondrocytes. Chondrocyte cultures were treated with
EHNA to block intracellular adenosine metabolism by
ADA (see below) and the uptake of radioactive adenosine
was measured, in the presence and absence of the trans-
porter inhibitor, NBTI. Control cells, which had not been
treated with any radioisotope, showed only background lev-
els of radioactivity (Fig. 5). Incubation of MC615 cells for
a period of 5 min with 10 mCi of [3H] adenosine resulted in
uptake of the nucleotide into the cell (Fig. 5). This uptake
accounted for 1.4% of the total radioactivity present in the
medium (containing 100 mM EHNA). Treatment of cells
with 1 mM NBTI resulted in a 79.5% reduction in adenosine
uptake, 10 mM NBTI, an 87.6% reduction and 100 mM NBTI,
a 97.5% reduction (P¼ 0.02). The morphology of the cells
remained normal indicating that these effects were not sim-
ply due to cytotoxicity of NBTI. There was no uptake of [14C]
inulin into the cells in either the presence or absence of
NBTI (data not shown).
THE EFFECT OF INHIBITORS OF PURINE METABOLISM
ON CELL NUMBER IN MC615 CELLS
To investigate the involvement of the ADA, AK and HC
pathways in adenosine-mediated cell death, cells were trea-
ted with selective and non-selective inhibitors to ADA
Fig. 5. Uptake of [3H] adenosine following treatment of cells with
varying concentrations of the adenosine transporter inhibitor,
NBTI. Cells were pre-treated with 100 mM EHNAþ 1.0e100 mM
NBTI. Adenosine uptake was assessed following addition of
10 mCi [3H] adenosine in the presence of the inhibitors for 5 min
at 37(C. A dose responsive inhibition of uptake was observed in
cells treated with 100 mM NBTI. DPM, disintegrations per minute.
*P¼ 0.02, n¼ 6 (unpaired t-test). Two further independent experi-
ments gave very similar results.(EHNA) and AK (Itub) and with HC, in the presence and ab-
sence of 5 mM adenosine, for 9 h. Preliminary experiments
carried out using various concentrations of each of the com-
pounds showed a dose dependent effect on the number of
adherent cells remaining after each treatment. From these
experiments, the optimal concentration of each compound
which could be used without causing reduction in adherent
cell number was deduced and used for subsequent experi-
ments. Untreated cells showed the expected doubling of
the cell number from 1.6 106 cells/well to 3.2 106
cells/well over the course of the experiment (Fig. 6). Adeno-
sine (5 mM) treatment resulted in a small decrease in the cell
number compared to the control but this was not statistically
signiﬁcant. A similar effect was seen for 100 mM EHNA treat-
ment. However, incubation of the cells with adenosine -
EHNA resulted in a much greater decrease in cell
number. Visually the cells appeared degenerate, with loss
of normal rounded morphology. Increased detachment of
cells and cellular debris in the medium was also detected.
The effects of adenosineþEHNA were prevented if cells
were treated with the adenosine transporter inhibitor NBTI
(result not shown), indicating that they were dependent on
cellular uptake of adenosine. Treatment of cells with the
AK inhibitor, Itub, resulted in an 81% decrease in the adher-
ent cell number as compared to controls. The morphology
of the cells resembled that seen for adenosineþ EHNA
treatment. However, treatment with 10 mM Itub and adeno-
sine together decreased cell loss. Surprisingly, treatment of
cells with 1 mM HC resulted in a 13% increase in cell num-
ber, whereas HCþ adenosine induced a 76% decrease in
cell count and widespread cell detachment.
To investigate the interaction between the ADA, AK and
HC pathways, cells were incubated with each of the inhibi-
tors in the presence of HC. In each case the reduction in cell
Fig. 6. The effect of inhibitors of adenosine metabolism and HC on
chondrocyte proliferation in the presence or absence of adenosine.
Cells were pre-treated with 100 mM EHNA, 10 mM Itub, or 1 mM HC,
or with combinations of these, for 30 min prior to incubation with medi-
um containing the respective compound(s), with or without 5 mM
adenosine, for 24 h. Cells treated with HC alone or with HC þ adeno-
sine were not pretreated. Cells were trypsinised and counted. Results
are shown asmean cell number 105 S.E.M., n¼ 3 wells/treatment,
P values: Control vs adenosine¼NS,Control vsEHNA¼NS,Control
vs Itub ¼<0.001, Control vs HC ¼NS, EHNA þ adenosine vs
EHNA¼<0.001, Itubþ adenosine vs Itub¼NS, HCþ adenosine
vs HC ¼<0.001, Itub þHC vs HC ¼<0.001, EHNA þHC þ
adenosine vs EHNAþHC¼<0.001, EHNAþHCþ adenosine vs
EHNA þ adenosine ¼NS, Itub þHC þ adenosine vs Itub þ
adenosine ¼<0.05, I tub þHC þ adenosine vs HC or ad-
enosine¼<0.001, and ItubþHCþ adenosine vs ItubþHC¼NS.
(ANOVA) NS¼ not signiﬁcant. The results are representative of two
further independent experiments.
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treatment alone. However, in the presence of adenosine
these combinations were found to be much more detrimen-
tal to cell number (Fig. 6).
CHARACTERISATION OF THE CELL DEATH PATHWAY BY THE
DETECTION OF PROTEIN MARKERS OF APOPTOSIS
To investigate which pathway of apoptosis may be oper-
ational in cells treated with adenosine and EHNA or HC, the
protein expression of three caspases (caspase-3, -8 and -9)
and the DNA repair enzyme PARP was tested. The anti-
body used to detect caspase-3 recognises both the inactive
proenzyme (32e33 kDa) and the active forms (20 kDa frag-
ment and 12e13 kDa fragment) of the enzyme. Control,
adenosine-treated, EHNA-treated and HC-treated cells
exhibited the inactive 33 kDa protein. Treatment of cells
with 5 mM adenosineþ 100 mM EHNA, 5 mM adenosi-
neþ 1 mM HC, or 5 mM adenosineþ 100 mM EH-
NAþ 1 mM HC, resulted in the appearance of 20 kDa and
13 kDa fragments, indicating activation of caspase-3
[Fig. 7(A)]. EHNAþHC gave a similar result to controls.
Neither caspase-8 nor caspase-9 expression was detected
in both the treated and the untreated MC615 cell lysate
samples (data not shown).
Further evidence of caspase-3 activity was detected by
the presence of the inactivated form of the caspase-3
substrate, PARP. Cleavage of PARP to an 85 kDa frag-
ment was detected in adenosineþEHNA, adenosi-
neþHC, and adenosineþEHNAþHC-treated cultures
[Fig. 7(B)].
DNA FRAGMENTATION AFTER TREATMENT WITH ADENOSINE
AND EHNA OR HC
Untreated, adenosine-treated, EHNA-treated, and HC-
treated cells showed no evidence of DNA laddering. In
Fig. 7. Conversion of procaspase-3 to caspase-3 following treat-
ment of MC615 cells with adenosine and inhibitors of adenosine
metabolism or with HC. Cells were treated for 9 h at 37(C, after
which they were processed for Western blot analysis for (A) procas-
pase-3 (33 kDa) and caspase-3 (20 kDa and 13 kDa) and (B)
PARP (33 kDa). Treatments were as follows: lane 1, no treatment;
lane 2, adenosine; lane 3, HC; lane 4, HCþ adenosine; lane 5,
EHNA; lane 6, EHNAþ adenosine; lane 7, EHNAþHC; and lane
8, EHNAþHCþ adenosine. The 20 kDa and 13 kDa cleavage
products of activated caspase-3 were detected in cultures treated
with HCþ adenosine (lane 4), EHNAþ adenosine (lane 6) and EH-
NAþHCþ adenosine (lane 8). Proteolytic processing of PARP to
an inactive 85 kDa product was also detected with these treat-
ments. The blots are representative of duplicate cultures for each
condition. Two further independent experiments gave the same
result.these cases, a tight high molecular weight DNA band was
observed. Laddering was clearly detected in adenosineþ
EHNA-treated and in adenosineþHC-treated cells. This
laddering was prevented when the caspase inhibitor, Z-
VAD-FMK, was included. However, in this case a much
broader high molecular weight DNA band was seen
(Fig. 8). Treatment with the caspase inhibitor alone, or in
Fig. 8. DNA laddering in cells treated with EHNAþ adenosine and
HCþ adenosine and the effect of the caspase inhibitor, Z-VAD-
FMK. Cells were treated for 9 h with 5 mM adenosine and
100 mM EHNA or 1 mM HC, in the presence or absence of the cas-
pase inhibitor (75 mM). DNA fragmentation was assessed as de-
scribed in the Methods. Lane M, DNA size marker; lane 1, DNA
fragment positive control supplied with kit; lane 2, untreated control;
lane 3, caspase inhibitor alone; lane 4, adenosine alone; lane 5, ad-
enosineþ caspase inhibitor; lane 6, adenosineþEHNA; lane 7,
adenosineþEHNAþ caspase inhibitor; lane 8, EHNA alone; lane
9, adenosineþHC; lane 10, adenosineþHCþ caspase inhibitor;
and lane 11, HC alone. Laddering is present after treatment with ei-
ther adenosineþEHNA (lane 6) or adenosineþHC (lane 9). Both
effects are counteracted by co-incubation with the caspase inhibitor
(lanes 7 and 10). The gel is representative of duplicate cultures for
each treatment. Two further independent experiments gave the
same result.
Fig. 9. The effect of adenosine on chondrocytes in vivo in CBA mu-
rine knee joints. The 8-week-old disarticulated CBA knee joints
were cultured in media containing 5 mM adenosine in the presence
or absence of 100 mM EHNA. Control knee joints treated with
EHNA alone show very few TUNEL positive cells (A) (25). Co-in-
cubation with 5 mM adenosine results in a large increase in the
number of TUNEL positive cells (B) (30).
493Osteoarthritis and Cartilage Vol. 14, No. 5combination with adenosine, had no effect on DNA. These
results are consistent with the cell count data.
VALIDATION OF THE EFFECTS OF ADENOSINE ON
CHONDROCYTE CELL DEATH IN CARTILAGE
To validate the effect of adenosine on chondrocyte cell
death in situ, 8-week-old CBA mouse knee joints were cul-
tured in medium containing adenosine (5 mM) and EHNA
(100 mM) and the effect on cell death was observed by de-
tecting TUNEL positive cells. Very few TUNEL positive cells
were detected in the control joints (Fig. 9). Any cells that
were present were randomly located in the articular carti-
lage. No difference was seen between the chondrocytes
of the medial and lateral tibial plateaux in this respect. In
contrast, results obtained for treated joints were quite differ-
ent. TUNEL positive cells were observed throughout the full
depth of the cartilage, with virtually all cells staining positive
(Fig. 9). This phenomenon was not speciﬁc to the medial
compartment.
Discussion
Our results show that in the locality of OA lesions in STR/
ort mice, 50NT activity is increased in chondrocytes through-
out the full depth of the medial tibial cartilage, when com-
pared with non-lesional areas. The distribution of the
increased 50NT activity in damaged areas corresponds
closely to the distribution of chondrocytes which stain posi-
tively for TUNEL and which show ultrastructural features in-
dicative of cell death in the STR/ort medial tibial plateau26.
Any 50NT activity detected in young pre-lesional mice, or in
non-lesional areas of older STR/ort mice, or in non-arthritic
CBA mice, was localised predominantly in the superﬁcial
zone of the articular cartilage. Why superﬁcial zone cells
constitutively express 50NT activity in normal cartilage is
not known, but these cells are specialised, as shown by
their synthesis of a speciﬁc matrix protein exclusive to this
zone29.
Increased 50NT activity in osteoarthritic cartilage would
result in increased production of adenosine, a factor known
to induce cell death in some cell types. Chondrocyte apo-
ptosis is a feature of murine, as well as of human OA26.
To investigate whether high concentrations of adenosine in-
duce cell death in murine chondrocytes and by what mech-
anism, we carried out experiments on the murine
chondrocyte cell line, MC615. This cell line is exceptionally
well differentiated and expresses classic markers of the
chondrocytic phenotype including types II, IX and XI colla-
gen, aggrecan and link protein30. The requirement for large
numbers of chondrocytes for our in vitro experiments pre-
cluded the use of primary chondrocytes isolated from mu-
rine articular cartilage which cannot be obtained in
sufﬁcient numbers for this. Extracellular adenosine signals
cells via transmembrane ARs which couple intracellularly
to adenyl cyclase (AC). The expression of ARs varies de-
pending on tissue type. Human articular chondrocytes
strongly express the A2b receptor subtype and weakly ex-
press the A2a receptor31. The A1 and A3 receptors are
not expressed. There is currently no published information
about AR expression in primary murine chondrocytes. How-
ever, RT-PCR showed that the murine MC615 chondro-
cytes express the A2b subtype prominently, whilst only
weakly expressing A2a. They also express the A1 receptor
very weakly, like human chondrocytes, but not A3. Further
proof for the presence of active A1 and A2 receptor sub-
types in MC615 cells was obtained by stimulating the cellswith selective and non-selective AR agonists. However,
whilst selective receptor stimulation modulated cAMP levels
it failed to induce DNA fragmentation in MC615 cells. Thus,
it is unlikely that adenosine induces chondrocyte cell death
through cell surface receptors. Nevertheless, it is notewor-
thy that stimulation of the A2 subtype in rat mesangial cells
by adenosine stimulates the activity of 50NT32.
Adenosine uptake is mediated via adenosine transporters
in most of the tissues33 and uptake is required for its cyto-
toxic effect in mouse neuroblastoma cells4. We found that
adenosine is taken up by MC615 cells and that this can
be inhibited by the transporter inhibitor NBTI. The presence
of adenosine transporters in murine chondrocytes has not
been established previously. Incubation of MC615 chondro-
cytes with 5 mM adenosine alone induced a 30e50% re-
duction in the number of adherent cells but was not
sufﬁcient to induce cell death, as indicated by a lack of
DNA fragmentation, caspase-3 activation or PARP cleav-
age. Very few ﬂoating cells were detected in the medium
in these cultures, implying that the reduction in cell number
might be due to a decrease in cell proliferation. However,
treatment of MC615 with adenosine in the presence of the
ADA inhibitor, EHNA, resulted in a far greater reduction in
cell number accompanied by DNA fragmentation, cas-
pase-3 activation and PARP cleavage. EHNA treatment
alone did not have this effect. Thus it seems likely that
when adenosine is taken up by the cell and its degradation
blocked by EHNA, its intracellular concentration increases
sufﬁciently to induce apoptosis. This interpretation is sup-
ported by the ﬁnding that equine chondrocytes treated
with EHNA accumulate adenosine34. Treatment of the cells
with the AK inhibitor, Itub, was cytotoxic, presumably due to
a loss of ATP generating capacity, but could be partly
rescued by exogenous adenosine. We speculate that,
in vivo, high 50NT activity in osteoarthritic STR/ort chondro-
cytes would likely increase extracellular adenosine levels. A
physiological age-related decline in the ADA activity may re-
duce these cells’ capacity to remove increased adenosine
taken up via the transporter, resulting in high intracellular
levels, inducing apoptosis. The speciﬁc activity of rat myo-
cardial ADA decreases with age35.
Adenosine can also be metabolised through the HC path-
way (Fig. 1). The function of this pathway is to provide
a source of activated methyl groups for methylation reac-
tions in the cell. SAM is converted to SAH with the release
of active methyl groups. The SAH is then hydrolysed to HC
which, on addition of a methyl group from N5-methyltetra-
hydrafolate, regenerates methionine. During pathological
situations, SAH accumulates and has been reported to ag-
gravate adenosine-mediated cell death6. Treatment of
MC615 cells with 1 mM HC resulted in an increase in cell
number, as it did also in rat aortic smooth muscle cells in
which DNA synthesis was stimulated by 4.5-fold36. However,
human umbilical vein endothelial cells show a dose depen-
dent decrease in DNA synthesis in response to HC17.
Treatment of MC615 cells with 5 mM adenosine and
1 mM HC together induced a large reduction in the number
of adherent cells, DNA fragmentation and activation of cas-
pase-3, indicating induction of apoptosis, an effect not ob-
served with either agent alone. Moreover this combination
supplemented by either of the inhibitors (EHNA or Itub) fur-
ther increased cell death. SAM can also serve as a propyl-
amine donor in the synthesis of the polyamines spermidine
and spermine. This normally accounts for not more than 5%
of SAM metabolism37. However, when both exogenous HC
(a precursor of methionine) and adenosine are present, in-
creased levels of SAM and its products, such as
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increased polyamines and induction of apoptosis has been
established recently in some cell types38,39 and spermine
triggers the activation of caspase-3 in both cell and cell
free systems40. Recent evidence indicates that polyamines
are important in tumour necrosis factor (TNF)-induced apo-
ptosis in chondrocytes since inhibiting their synthesis mark-
edly reduced DNA fragmentation and caspase-3 activation
induced by the cytokine41.
Procaspase-3 activation and cleavage of the DNA repair
enzyme PARP occurred only in the adenosineþEHNA and
adenosineþHC-treated cultures and provide ﬁrm evidence
of chondrocyte apoptosis in these conditions. In contrast,
caspase-8 and caspase-9 expression was not seen. Ku¨hn
and Lotz42 detected no procaspase-8 processing by immu-
noblotting after stimulating human chondrocytes with CD95
antibody, although the mRNA transcript of caspase-8 was
detected. It may be that the protein levels of some caspases
are very low or their half lives very short, making detection
difﬁcult. Alternatively the activation of caspase-3 in chon-
drocytes may not be mediated through any of the classical
pathways. For example, caspase-8 is thought to have an
obligatory role in apoptosis initiated by death receptors,
but Kischkel et al.43 found that caspase-10 could trigger
this pathway, independent of caspase-8.
Finally the ﬁnding that many TUNEL positive chondro-
cytes were present through the full depth of the cartilage
when disarticulated CBA mouse knee joints were incubated
in media containing adenosineþ EHNA indicates that high
levels of adenosine can directly induce cell death in murine
articular cartilage. This adds further support to the proposal
that chondrocyte death in the STR/ort mouse model of
OA26 may be driven, at least in part, by increased adeno-
sine production by 50NT. It seems likely that for normal car-
tilage function, extracellular adenosine levels must be quite
tightly regulated since depletion leads to increased glycos-
aminoglycan (GAG) release and the production of matrix
metalloproteinase (MMP)-3, MMP-13, prostaglandin E2
(PGE2) and nitric oxide (NO)
44, whilst increases may trig-
ger cell death.
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